Test of CP003 for chronic fatigue or long COVID tiredness
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study tests a new supplement called CP003 to see if it helps reduce tiredness in people with chronic fatigue syndrome or long COVID fatigue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of chronic fatigue syndrome (CFS/ME) or long-lasting tiredness after COVID-19.
- You can commit to joining a 6-week program and filling out online surveys.
- You have not taken any herbal supplements or complementary medicines in the last 6 months.
- You do not have a serious medical condition or an active infection like a bad flu.
- You are not pregnant or planning to become pregnant in the next 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a traditional Chinese medicine, Shengmai Liquid, can help reduce fatigue in people with long COVID. It is for adults aged 18 to 75 who feel tired for a long time after a COVID infection.
This study tests a program to help reduce fatigue and other symptoms in people with Long COVID. It involves using an internet-connected device to access the program remotely.
This study tests whether improving diet quality can reduce fatigue and symptoms in people with long-COVID (post-acute COVID-19 syndrome). It may help if your diet quality is currently low and your fatigue is moderate to severe.
This trial tests a natural compound to see if it can reduce ongoing inflammation and symptoms like fatigue, brain fog, or shortness of breath that linger after a COVID-19 infection. It's for people who still have symptoms at least 2 months after getting sick.
This study tests whether acupuncture can help improve thinking and memory problems in people with long-term fatigue after COVID-19 (often called ME/CFS). If you have had fatigue for at least 6 months after a COVID-19 infection and meet specific criteria, this trial may offer a non-drug treatment option.
This trial tests whether a traditional Chinese medicine formula (Yiqi Fuyuan Paste) can help reduce fatigue in people with chronic fatigue syndrome. It is a double-blind, placebo-controlled study, meaning neither you nor the doctor will know which treatment you receive.
Hear when a new Chronic Fatigue Syndrome (CFS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.